NAD+ appears regularly in discussions about longevity, cellular energy, and metabolic health research, often alongside peptides and other compounds associated with the same field. This proximity can create the impression that NAD+ belongs to the same category. However, NAD+ is not a peptide, it is a distinct class of molecule with
When people encounter Peptide Therapy research for the first time, it can seem like a recent development, especially with the new “boom” online. The history of peptides in scientific research stretches back well over a century, with roots in some of the most significant discoveries in the entire history of medicine.
Cardiovascular science is one of the most extensively researched areas in medicine. Within it, a relatively niche but scientifically distinct field has developed over several decades: the study of heart bioregulators. Heart bioregulators are short peptide complexes derived from cardiac tissue and are studied for their role in cardiac gene expression
BPC-157 is one of the most extensively researched peptides in the field of regenerative science. It is documented effects across tissue repair, wound healing, gastrointestinal protection, and angiogenesis have made it a compound of significant interest to researchers, practitioners, and individuals pursuing health optimisation. As its profile has grown, so has
A significant peptide update in 2026 has set in motion a significant regulatory shift for some of the most widely researched compounds in the peptide space. Following an announcement by Robert F. Kennedy Jr., United States Secretary of Health and Human Services, 12 peptides previously classified under FDA Category 2 will
In a February 27, 2026 appearance on the Joe Rogan Experience podcast, Health and Human Services Secretary Robert F. Kennedy Jr. articulated intentions to pursue reclassification of approximately 14 peptides from FDA Category 2 status back to Category 1, a policy reversal that, if implemented, would restore legal compounding access to
Dr. Vladimir Khavinson, a renowned Russian gerontologist and professor, has revolutionized the field of peptide therapies. His groundbreaking work in bioregulation and longevity has earned him global recognition. As a member of the Russian Academy of Sciences and the Russian Academy of Medical Sciences, Khavinson has made significant contributions to our
